Journal
BIOCHEMICAL PHARMACOLOGY
Volume 76, Issue 11, Pages 1459-1475Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2008.07.013
Keywords
Sanguinarine; K1735-M2 rat melanoma cells; Liver mitochondria; Mitochondrial physiology; Cell proliferation; Mitochondrial permeability transition; Bioenergetics; Apoptosis
Categories
Funding
- Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU/OSM/64084/2006]
- TLS [SFRH/BD/38067/2007]
- VAS [SFRH/BPD/ 31549/2006]
- GCP [SFRH/BD/36938/2007]
- AFB [SFRH/BD/41384/2007]
- SLP [SFRH/BD/37933/2007]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/37933/2007, SFRH/BD/36938/2007, SFRH/BD/41384/2007] Funding Source: FCT
Ask authors/readers for more resources
Sanguinarine (SANG) is an alkaloid recognized to have anti-proliferative activity against various human tumour cell lines. No data is available on the susceptibility of advanced malignant melanoma to SANG, although this disease has a very poor prognosis if not detected in time due to the resistance to conventional chemotherapy. The present work was designed to study the nuclear and mitochondrial involvement in the pro-apoptotic effect of SANG in an invasive mouse melanoma cell line. The results obtained show that SANG is primarily accumulated by the cell nuclei, causing inhibition of cell proliferation and inducing cell death, as confirmed by an increase in sub-G1 peaks. At low concentrations, SANG induces mitochondrial depolarization in a sub-population of melanoma cells, which also generally displayed strong nuclear labelling of phosphorylated histone H2AX. Western blotting revealed an increase in p53, but not Bax protein, in both whole-cell extracts and in mitochondrial fractions. isolated hepatic mitochondrial fractions revealed that SANG affects the mitochondrial respiratory chain, and has dual effects on mitochondrial calcium loading capacity. We suggest that SANG is able to induce apoptosis in metastatic melanoma cells. The knowledge of mitochondrial vs. nuclear effects of SANG is important in the development of this promising compound for clinical use against aggressive melanoma. (C) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available